Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ertugliflozin trial in type 2 diabetes and heart failure
2017-001840-37Phase 2Active
- Sponsor
- VU University Medical Center
- Start
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of ertugliflozin in type 2 diabetes mellitus (T2DM) and heart failure (HF), sponsored by VU University Medical Center. Primary endpoint: Fractional excretion of sodium. Started Jun 2018; status: active.
02
Drugs
ertugliflozin
03
Conditions
type 2 diabetes mellitus (T2DM)heart failure (HF)
Beyond the preview
Go deeper on 2017-001840-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-001840-37.